Aranscia Acquires YouScript from Invitae

Aranscia, a global provider of diagnostics software, services, and testing solutions, and Invitae Corporation, a leading medical genetics company, today announced that Aranscia has acquired select assets of the YouScript personalized medication management platform from Invitae Corporation in an all-cash transaction. YouScript is a widely recognized leader in providing actionable, real-time medication risk and pharmacogenomics (PGx) insights that enable healthcare providers and organizations to build, deliver, and scale comprehensive personalized medication management programs. YouScript’s foundational peer-reviewed research initiatives span more than two decades and have continuously demonstrated the benefit of incorporating PGx testing into medication management programs that improve outcomes, reduce adverse events and healthcare spend, and drive efficiency for clinical professions within their existing operational workflows. YouScript will join the Aranscia portfolio of companies, each of which shares a synergistic mission of solving the tactical gaps in clinical workflows and democratizing access to the promises of precision medicine. This portfolio includes 2bPrecise, the award-winning suite of lab-agnostic, EMR-integrated solutions for PGx, population health insights, and precision oncology workflows; SinguLab, a national network of diagnostics services support; and AccessDx Laboratory, a CLIA-certified, CAP accredited, and NYCQ molecular diagnostic laboratory with s...
Source: EMR and HIPAA - Category: Information Technology Authors: Tags: Health IT Company Healthcare IT 2bPrecise AccessDX Laboratory Aranscia Health IT Acquisitions Healthcare M&A Invitae Corporation Joe Spinelli Kristine Ashcraft SinguLab YouScript Source Type: blogs